This project focuses on underlying mechanisms leading to onset of primary Sjogren’s syndrome with focus on transition of asymptomatic autoantibody positive individuals to full blown disease. We will examine glycosylation profiles of autoantibodies and perform high end flowcytometry and singlecell
RNA sequencing in various phases of the disease. This will permit to delineate the ideal stage for immune intervention.